STAT+: Soleno Therapeutics responds to short seller’s Prader-Willi drug safety claims
Written by
STAT News
Published
0
comments
0
min
Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly approved therapy.